Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  08/16/2001
 
Trade Name:  Epivir-HBV
 
Generic Name or Proper Name (*):  lamivudine
 
Indications Studied:  Treatment of Chronic Hepatitis B
 
Label Changes Summary:  Safety and effectiveness established down to 2 years Established a dose of 3mg/kg/day up to a maximum of 100mg/day (adult dose)
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B):  B
 
Sponsor:  GlaxoSmithKline
 
Pediatric Exclusivity Granted Date:  07/25/2001
 
NNPS:  FALSE'
 
Therapeutic Category:  Antiviral
 
-
-